Sympazan 5 mg Oral Film
RxNorm 2102717
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2102717 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Sympazan 5 mg Oral Film.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Clobazam 5 mg Oral Film [Sympazan]
(Atom ID: 11814760)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
CloBAZam 5 mg Oral Film [Sympazan]
(Atom ID: 12430241)
PSNPrescribable
Prescribable Name (PSN):
Sympazan 5 mg Oral Film
(Atom ID: 11814761)
SYPrescribable
Synonym (SY):
Sympazan 5 mg Oral Film
(Atom ID: 11814762)
Patient Education
Clobazam
Clobazam is used with other medication(s) to control seizures in adults and children 2 years of age and older who have Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). Clobazam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.